Los Angeles, CA -- (SBWire) -- 02/02/2019 --Global Bacterial Vaginosis Drug market report is first of its kind research report that covers the overview, summary, market dynamics, competitive analysis, and leading player's various strategies to sustain in the global market. The Bacterial Vaginosis Drug report covers the five top regions of the globe and countries within, which shows the status of regional development, consisting of market value, volume, size, and price data.  Apart from this, the Bacterial Vaginosis Drug report also covers detail information about various clients which is the most significant element for the manufacturers.

Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria.
The classification of bacterial vaginosis drug includes Rx and OTC, and the proportion of OTC in 2016 is about 72%.

Bacterial vaginosis drug is widely sold in hospital, pharmacy and another field. The most proportion of bacterial vaginosis drug is sold in the pharmacy, and the revenue in 2016 is about 423 M USD.

USA region is the largest supplier of bacterial vaginosis drug, with a revenue market share nearly 32% in 2016. Europe is the second largest supplier of Bacterial Vaginosis Drug, enjoying revenue market share nearly 30% in 2016. The USA and Europe are the largest consumption places, with the consumer market share nearly 28% in 2016.

Market competition is intense. Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Get PDF report template at https://www.qyresearch.com/sample-form/form/949345/global-bacterial-vaginosis-drug-market

The global Bacterial Vaginosis Drug market is valued at 800 million US$ in 2018 is expected to reach 1030 million US$ by the end of 2025, growing at a CAGR of 3.2% during 2019-2025.

This report focuses on Bacterial Vaginosis Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Bacterial Vaginosis Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, and Japan.

At the company level, this report focuses on the production capacity, ex-factory price, revenue, and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Bayer

Pfizer

Sanofi

Piramal

Abbott

Galderma

Mission

Alkem

Xiuzheng

Teva

Perrigo

West-Ward

HPGC

Yunnan Baiyao

Starpharma

Novel

Edenvridge

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Rx

OTC

Segment by Application

Hospital

Pharmacy

Other

Get Complete Report in your Inbox within 24 hours  at https://www.qyresearch.com/index/detail/949345/global-bacterial-vaginosis-drug-market

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.